Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 9, 2003, Pages 880-884

  Yli Kerttula, T ^a   Luukkainen, R ^a   Yli Kerttula, U ^b   Mottonen T ^a   Hakola, M ^c   Korpela, M ^b   Sanila, M ^a   Uksila, J ^a   Toivanen, A ^a  

^a Satalinnan Sairaala   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HLA B7 ANTIGEN;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; RHEUMATIC DISEASE; SPONDYLOARTHROPATHY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; ANTI-INFECTIVE AGENTS; ARTHRITIS, REACTIVE; CHRONIC DISEASE; CIPROFLOXACIN; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HLA-B27 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 0042386353     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.9.880     Document Type: Article

References (45)

1. Peterson MC. Rheumatic manifestations of Campylobacter jejuni and C. fetus infections in adults. Scand J Rheumatol 1994;23:167-70.
2. Toivanen A, Toivanen P. Aetiopathogenesis of reactive arthritis. Rheumatol Europe 1995;24:5-8.
3. Paronen I. Reiter's disease. A study of 344 cases observed in Finland. Acta Med Stand 1948;131(suppl 212):1-113.
4. Sairanen E, Paronen I, Mähönen H. Reiter's syndrome: a follow-up study. Acta Med Scand 1969;185:57-63.
5. Bardin T, Enel C, Cornelis F, Salski C, Jorgensen C, Ward R, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992;35:190-4.
6. Konttinen YT, Nordström DC, Bergroth V, Leirisalo-Repo M, Santavirta S. Occurrence of different ensuing triggering infections preceding reactive arthritis: a follow up study. BMJ 1988;296:1644-5.
7. Leirisalo M, Skylv G, Kousa M, Voipio-Pulkki L-M, Suoranta H, Nissilä M, et al. Follow up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982;25:249-59.
8. Leirisalo-Repo M, Helenius P, Hannu T, Lehtinen A, Kreula J, Taavitsainen M, et al. Long term prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997;56:516-20.
9. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
10. Csonka GW. Long-term follow-up and prognosis of Reiter's syndrome. Ann Rheum Dis 1979;38(suppl):24-8.
11. Thomson GTD, Alfa M, Orr K, Thomson BRJ, Olson N. Secretory immune response and clinical sequelae of salmonella infection in a point source cohort. J Rheumatol 1994;21:132-7.
12. Kvien TK, Glennás A, Melby K, Husby G. The natural history of reactive arthritis. Rheumatol Europe 1995;24:15-19.
13. Yli-Kerttula T, Tertti R, Toivanen A. Ten-year follow up study of patients from a Yersinia pseudotuberculosis III outbreak. Clin Exp Rheumatol 1995;13:333-7.
14. Bleehen SS, Everall JD, Tighe JR. Amyloidosis complicating Reiter's syndrome. Br J Vener Dis 1966;42:88-92.
15. Caughey DE, Wakem CJ. A fatal case of Reiter's disease complicated by amyioidosis. Arthritis Rheum 1973;16:695-700.
16. Wattioux MJ, Bourgeois P, Picard O, Bennani M, Thomas M, Desproges-Gotteron R, et al. Two familial cases of malignant Reiter's syndrome. Clin Exp Rheumatol 1989;7:541-5.
17. Yli-Kerttula T, Möttönen T, Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one. J Rheumatol 1997;24:2047-50.
18. Toivonen A, Granfors K, Lahesmaa-Rantala R, Leino R, Ståhlberg T, Vuento R. Pathogenesis of yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev 1985;86:47-70.
19. Lahesmoo-Rontolo R, Granfors K, Isomäki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987;46:510-14.
20. Gronfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomäki O, Pekkola-Heino K, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N E ngl J Med 1989;320:216-21.
21. Granfors K, Jalkanen S, Lindberg AA, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990;335:685-8.
22. Merilahti-Palo R, Söderström K-O, Lahesmaa-Rantala R, Granfors K, Toivanen A. Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis. Ann Rheum Dis 1991;50:87-90.
23. Granfors K, Jalkanen S, Toivanen P, Koski J, Lindberg AA. Bacterial lipopolysaccharide in synovial fluid cells in shigella triggerered reactive arthritis. J Rheumatol 1992;19:500.
24. Schumacher HR, Magge S, Cherian PV, Sieckman J, Rothfuss S, Clayburne G, et al. Light and electron microscopic studies on the synovial membrane in Reiter's syndrome, Immunocytochemical identification of chlamydial antigen in patents with early disease. Arthritis Rheum 1988;31:937-46.
25. Hammer M, Nettelnbreker E, Hopf S, Schmitz E, Pörschke K, Zeidler H. Chlamydial rRNA in the joints of patients with chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol 1992;10:63-6.
26. Hoogkamp-Korstanje JAA, de Koning J, Heesemann J. Persistence of Yersinia enterocolitica in man. Infection 1988;16:81-5.
27. Toivanen A. Bacteria-triggered reactive arthritis. Implications for antibacterial treatment. Drugs 2001;61:343-51.
28. Fryden A, Bengtsson A, Foberg U, Svenungsson B, Castor B, Kärnell A, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and serological study. BMJ 1990;301:1299-302.
29. Locht H, Kihlström E, Lindström FD. Reactive arthritis after salmonella among medical doctors- study of an outbreak. J Rheumatol 1993;20:845-8.
30. Mattila L, Leirisalo-Repo M, Pelkonen P, Koskimies S, Granfors K, Siitonen A. Reactive arthritis following an outbreak of Salmonella Bowismorbificans infection. J Infect 1998;36:289-95.
31. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis 2002;61:264-6.
32. Lauhio A, Leirisalo-Repo M, Löhdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
33. Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993;11:301-7.
34. Hoogkamp-Korstanje JAA, Moesker H, Bruyn GAW. Ciprofloxacin v placebo for treatment of Yersinia enterocolitica triggered reactive arthritis. Ann Rheum Dis 2000;59:914-17.
35. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000;59:565-70.
36. Sieper J, Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Hiepe F, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum 1999;42:1386-96.
37. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
38. Schober P. Lendenwirbelsäule und Kreuzschmerzen. Munch Med Wschr 1937;84;336-8.
39. Dougodos M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
40. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;217:361-8.
41. Ekman P, Kirveskari J, Granfors K. Modification of disease outcome in salmonella-infected patients by HLA-B27. Arthritis Rheum 2000;43:1527-34.
42. Laivoranta S, Ilonen J, Tuokko J, Luukkainen R, Toivanen A. HLA frequencies in HLA-B27 negative patients with reactive arthritis. Clin Exp Rheumatol 1995;13:637-40.
43. Wollenhaupt J, Hammer M, Pott HG, Zeidler H. A double-blind placebo-controlled comparison of 2 weeks versus 4 months treatment with doxycycline in chlamydia-induced arthritis [abstract]. Arthritis Rheum 1997;40(suppl):S143.
44. Zhang Y, Gripenberg-Lerche C, Söderström K-O, Toivanen A, Toivanen P. Antibiotic prophylaxis and treatment of reactive athritis. Arthritis Rheum 1996;39:1238-43.
45. Zhang Y, Toivanen A, Toivanen P. Experimental yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin. Br J Rheumatol 1997;36:541-6.